110. Poddar P., Sivasubramanian N., DiBello P.M. et al. Homocysteine induces expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human aortic endothelial cells: implications for vascular disease // Circulation. 2011. Vol. 103, № 22. P. 2717–2723.
111. Gris J.C., Quere I., Sanmarco M. et al. Antiphospholipid and antiprotein syndromes in non-thrombotic, non-autoimmune women with unexplained recurrent primary early foetal loss // Thromb. Haemost. 2000. Vol. 84, № 2. P. 228–236.
112. Zhang X., Li H., Jin H. et al. Effects of homocysteine on endothelial nitric oxide production // Am. J. Physiol. Renal. Physiol. 2000. Vol. 279. P. F671–678.
113. Coumans A.B., Huijgens P.C., Jakobs C. et al. Haemostatic and metabolic abnormalities in women with unexplained recurrent abortion // Hum. Reprod. 1999. Vol. 14, № 1. P. 211–214.
114. Wouters M.G., Boers G.H., Blom H.J. et al. Hyperhomocysteinemia: a risk factor in women with unexplained recurrent early pregnancy loss // Fertil. Steril. 1993. Vol. 60, № 5. P. 820–825.
115. Nelen W.L., Blom H.J., Steegers E.A. et al. Hyperhomocysteinemia and recurrent early pregnancy loss: a meta-analysis // Fertil. Steril. 2000. Vol. 74, № 6. P. 1196–1199.
116. Del Bianco Maruotti A.G., Fulgieri A.M. et al. Recurrent spontaneous miscarriages and hyperhomocysteinemia // Minerva Ginecol. 2004. Vol. 56, № 3. P. 379–383.
117. Branch D.W., Porter T.F., Rittenhouse L. et al. Antiphospholipid antibodies in women at risk for pre eclampsia // Am. J. Obstet. Gynaecol. 2001. Vol. 184. P. 823–834.
118. Ogasawara M., Aoki K., Katano K. et al. Activated partial thromboplastin time is a predictive parameter for further miscarriages in cases of recurrent fetal loss // Fertil. Steril. 1998. Vol. 70, № 6. P. 1081–1084.
119. Clark D.A., Chaouat G., Arck P.C. et al. Cytokine-dependent abortion in CBAxDBA/2 mice is mediated by the prokoaguland fg 12 prothrombinase // J. Immunol. 1998. Vol. 160. P. 545–549.
120. Gueant J.L., Candito M., Andres E. et al. Familial pernicious anaemia with hyperhomocysteinaemia in recurrent early pregnancy loss // Thromb. Haemost. 2004. Vol. 92. P. 1147–1149.
121. Тетруашвили Н.К., Сидельникова В.М., Верясов В.М. и др. Роль системы цитокинов в патогенезе привычного выкидыша и преждевременных родов // Вести. Рос. ассоц. акуш.-гин. 1999. № 3. С. 37–45.
122. Brenner B., Bar J., Ellis M. et al. Effects of enoxaparin on late pregnancy complications and neonatal outcome in women with recurrent pregnancy loss and thrombophilia: results from the Live-Enox study // Fertil. Steril. 2005. Vol. 84, № 3. P. 770–773.
123. Rai R., Cohen H., Dave M. et al. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies) // BMJ. 1997. Vol. 314, № 7076. P. 728–736.
124. Quenby S., Mountfield S., Cartwright J.E. et al. Effects of low molecular-weight and unfractionated heparin on trophoblast function // Obstet. Gynecol. 2004. Vol. 104. P. 354–361.
125. Nelson S.M., Greer I.A. The potential role of heparin in assisted conception // Hum. Reprod. Update. 2008. Vol. 14, № 6. P. 623–645.
126. Isermann B., Sood R., Pawlinski R. et al. The thrombomodulin-protein C system is essential for the maintenance of pregnancy // Nat. Med. 2003. Vol. 9, № 3. P. 331–337.
127. Oberkersch R., Attorresi A.I., Calabrese G.C. Low-molecular-weight heparin inhibition in classical complement activation pathway during pregnancy // Thromb. Res 2010. Vol. 125, № 5. P. 240–245.
128. Girardi G., Redecha P., Salmon J.E. Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation // Nat. Med. 2004. Vol. 10, № 11. P. 1222–1226.
129. Di Simone N., Tersigni C., Di Nicuolo F. et al. Low molecular weight heparin actions on human endometrial angiogenesis // Thromb. Research. 2011. Vol. 127, suppl. 3. P. 125–25.
130. Blumenfeld Z., Brenner B. Thrombophilia-associated pregnancy wastage // Fertil. Steril. 1999. Vol. 72. P. 765–774.
131. Clark P., Walker I.D., Langhorne P. et al. SPIN (Scottish Pregnancy Intervention) study: a multicenter, randomized controlled trial of low-molecular-weight heparin and low-dose aspirin in women with recurrent miscarriage // Blood. 2010. № 115. P. 4162–4167.
132. Макацария А.Д., Бицадзе В.О., Акиньшина С.В. и др. Применение низкомолекулярного гепарина в акушерской, гинекологической и онкологической практике // Consilium Medicum. 2005. № 7. С. 35–41.